Can inhaled oxygen cause cancer?

January 13, 2015

The ancient physician/alchemist, Paracelsus, said: "The dose makes the poison." According to a new study published in PeerJ, even oxygen may fall prey to the above adage. While essential to human life, aspects of oxygen metabolism may promote cancer. Capitalizing on the inverse relationship of oxygen concentration with elevation, researchers found lower rates of lung cancer at higher elevations, a trend that did not extend to non-respiratory cancers, suggesting that carcinogen exposure occurs via inhalation.

In the United States, lung cancer is responsible for 27% of all cancer deaths, claiming an estimated 160,000 lives per year [1]. While smoking is linked to as many as 90% of lung cancer cases, this new study suggests that atmospheric oxygen may play a role in lung carcinogenesis.

Oxygen is highly reactive and even when it is carefully and quickly consumed by our cells, it results in reactive oxygen species (ROS) which can lead to cellular damage and mutation. While oxygen composes 21% of the overall atmosphere, lower pressure at higher elevations results in less inhaled oxygen - an effect which notoriously frustrates athletes at high altitudes. For example, across United States counties, elevation differences account for a 34.9% decrease in oxygen from Imperial County, California (-11 m) to San Juan County, Colorado (3473 m).

To investigate whether inhaled oxygen could be a human carcinogen, two researchers compared cancer incidence rates across counties of the elevation-varying Western US. They found that as county elevation increased, lung cancer incidence decreased. The effect was dramatic with incidence decreasing by 7.23 cases per 100,000 individuals for every 1,000 meter (3,281 feet) rise in elevation, equating to approximately 13% of the mean lung cancer incidence of 56.8 cases per 100,000 individuals. A variety of statistical techniques attested that the association was not due to chance.

The observed association does not prove that oxygen causes lung cancer. The study looked at groups of people rather than individuals and many variables in addition to oxygen levels are correlated with elevation. Accordingly the researchers performed a thorough analysis to investigate confounding potentials. Their model accounted for important risk and demographic variables, such as smoking prevalence and education. The association was consistent across population subgroups, states, and models that included a range of additional factors.

The researchers also evaluated breast, colorectal, and prostate cancer: the remaining three most common cancers in the United States. Elevation's association with these non-respiratory cancers was either weak or absent, supporting the hypothesis of an inhaled risk factor. Furthermore, environmental correlates of elevation, such as sun exposure and fine particulate matter (a measure of pollution), produced vastly inferior predictions of lung cancer incidence compared to elevation itself.

Two past epidemiological reports, looking at elevation as a confounder, proposed that elevation-dependent oxygen variation was responsible for lower cancer mortality at high elevation [2, 3]. Unlike the two previous studies, the current study was specifically designed to assess the effect of elevation and benefited from a recent proliferation of high-quality county-level data. In total, the study relied on over 30 variables with sufficient coverage and precision to enable the inclusion of ~250 Western US counties. Using high resolution census data, the researchers calculated elevation values that reflected population dispersion within each county, thereby more accurately estimating the atmospheric exposure of each county's populace. All resources were public, underscoring the importance of open data for future scientific discovery.

The research was published today in the peer-reviewed open access journal PeerJ ( Both authors are strong advocates for transparent science and open-access publishing and in addition to the full release of the dataset and analysis, the peer review history is also being made available by PeerJ---a nascent practice that is gaining popularity.

The authors hope additional researchers will focus their efforts on oxygen's role in human carcinogenesis. Analysis of diverse regions and individual-level datasets would contribute further epidemiological evidence. Ultimately, completely-controlled, experimental investigation using models of carcinogenesis will be critical to our understanding of the phenomenon.

If future analyses confirm oxygen-driven tumorigenesis, the medical implications could be large. For example, as the authors explain, "were the entire United States situated at the elevation of San Juan County, CO (3473 m), we estimate 65,496 fewer new lung cancer cases would arise per year." While the authors do not expect or recommend individuals to relocate based on this finding, identifying a universal and major risk factor could provide new insights into lung cancer etiology. From these insights, better treatments and preventative measures may arise.

[1] Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. doi:10.3322/caac.21208

[2] Weinberg CR, Brown KG, Hoel DG (1987) Altitude, radiation, and mortality from cancer and heart disease. Radiation Research. doi:10.2307/3577265

[3] Van Pelt WR (2003) Epidemiological associations among lung cancer, radon exposure and elevation above sea level. Health Physics. pubmed:13678279

EMBARGOED until January 13th 2015: 7 am EST; 12 midday UK time (i.e. the date of publication)

Abstract (from the article):

The level of atmospheric oxygen, a driver of free radical damage and tumorigenesis, decreases sharply with rising elevation. To understand whether ambient oxygen plays a role in human carcinogenesis, we characterized age-adjusted cancer incidence (compiled by the National Cancer Institute from 2005 to 2009) across counties of the elevation-varying Western United States and compared trends displayed by respiratory cancer (lung) and non-respiratory cancers (breast, colorectal, and prostate). To adjust for important demographic and cancer-risk factors, 8-12 covariates were considered for each cancer. We produced regression models that captured known risks. Models demonstrated that elevation is strongly, negatively associated with lung cancer incidence (p < 10^?16), but not with the incidence of non-respiratory cancers. For every 1,000 m rise in elevation, lung cancer incidence decreased by 7.23 99% CI [5.18-9.29] cases per 100,000 individuals, equivalent to 12.7% of the mean incidence, 56.8. As a predictor of lung cancer incidence, elevation was second only to smoking prevalence in terms of significance and effect size. Furthermore, no evidence of ecological fallacy or of confounding arising from evaluated factors was detected: the lung cancer association was robust to varying regression models, county stratification, and population subgrouping; additionally seven environmental correlates of elevation, such as exposure to sunlight and fine particulate matter, could not capture the association. Overall, our findings suggest the presence of an inhaled carcinogen inherently and inversely tied to elevation, offering epidemiological support for oxygen-driven tumorigenesis. Finally, highlighting the need to consider elevation in studies of lung cancer, we demonstrated that previously reported inverse lung cancer associations with radon and UVB became insignificant after accounting for elevation.


Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to